Keywords: sanofi-aventis, acomplia, step, closer, market, after, showing

Sanofi-Aventis' Acomplia a step closer to market after showing efficacy in obesity

Article | 25 April 2005

Print This

Results from a clinical study of French drugmaker Sanofi-Aventis' Acomplia (rimonabant), published in the April 16 issue of The Lancet, have ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in